303 related articles for article (PubMed ID: 25722112)
21. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
22. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM
BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653
[TBL] [Abstract][Full Text] [Related]
23. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
24. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
25. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
Hao JP; Ma A
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
[TBL] [Abstract][Full Text] [Related]
26. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
27. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
[TBL] [Abstract][Full Text] [Related]
28. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
29. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
30. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
31. Role of a novel circulatory RNA-based biomarker panel expression in ovarian cancer.
El-Shal AS; Matboli M; Abdelaziz AM; Morsy AA; Abdelbary EH
IUBMB Life; 2019 Dec; 71(12):2031-2047. PubMed ID: 31520466
[TBL] [Abstract][Full Text] [Related]
32. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer.
Zheng H; Zhang L; Zhao Y; Yang D; Song F; Wen Y; Hao Q; Hu Z; Zhang W; Chen K
PLoS One; 2013; 8(11):e77853. PubMed ID: 24223734
[TBL] [Abstract][Full Text] [Related]
33. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.
Wu J; Li L; Jiang C
Mol Neurobiol; 2015 Dec; 52(3):1540-1546. PubMed ID: 25367878
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
35. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
Pang PC; Shi XY; Huang WL; Sun K
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
[TBL] [Abstract][Full Text] [Related]
36. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
Chung YW; Bae HS; Song JY; Lee JK; Lee NW; Kim T; Lee KW
Int J Gynecol Cancer; 2013 May; 23(4):673-9. PubMed ID: 23542579
[TBL] [Abstract][Full Text] [Related]
37. Serum miR-16 as a potential biomarker for human cancer diagnosis: results from a large-scale population.
Huang Z; Chen W; Du Y; Guo Q; Mao Y; Zhou X; Hua D
J Cancer Res Clin Oncol; 2019 Mar; 145(3):787-796. PubMed ID: 30706130
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of serum miR-1204 and its potential as a biomarker for the diagnosis and prognosis of breast cancer.
Han S; Li P; Wang D; Yan H
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):732-736. PubMed ID: 32696863
[TBL] [Abstract][Full Text] [Related]
39. Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma.
Lai NS; Wu DG; Fang XG; Lin YC; Chen SS; Li ZB; Xu SS
Br J Cancer; 2015 Mar; 112(7):1241-6. PubMed ID: 25756397
[TBL] [Abstract][Full Text] [Related]
40. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
